Caleb M. Adler, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Alessandra Alciati, Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Como, Italy
George Anderson, Clinical Research Center Scotland and London, London, UK
Ana C. Andreazza, Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada
Michael Berk, School of Medicine, Deakin University, Geelong, VIC, Australia; Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia; Florey Institute for Neuroscience and Mental Health and Orygen Youth Health, University of Melbourne, Parkville, VIC, Australia
Emre Bora, Faculty of Medicine, Department of Psychiatry, Dokuz Eylul University, Izmir, Turkey; Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia
Elisa Brietzke, Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, RS, Brazil
Daniela Caldirola, Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Como, Italy
Sebastian Camino, Dr. Braulio A. Moyano Neuropsychiatric Hospital, Buenos Aires, Argentina
Ryan M. Cassidy, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center, Houston, TX, USA
Raphael Cerqueira, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, RS, Brazil
Melissa P. DelBello, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Lisia von Diemen, Center for Drug and Alcohol Research, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
Peter D. Drummond, School of Psychology and Exercise Science, Murdoch University, Perth, WA, Australia
Angela Duong, Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
Jenni Farrow, Department of Psychiatry and Behavioral Neurosciences, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Iria Grande, Hospital Clinic, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain
Jonathan M. Gregory, Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
Benjamin I. Goldstein, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Rajas P. Kale, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA; School of Engineering, Deakin University, Waurn Ponds, VIC, Australia
Flavio Kapczinski, Department of Psychiatry and Behavioural Neurosciences, Graduate Program in Neuroscience, McMaster University, Hamilton, ON, Canada
Marcia Kauer-Sant'Anna, Department of Psychiatry, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Postgraduate Program in Psychiatry, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
Flavia Lima, Postgraduate Program in Psychiatry, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
Adrian L. Lopresti, School of Psychology and Exercise Science, Murdoch University, Perth, WA, Australia
Michael Maes, School of Medicine, Deakin University, Geelong, VIC, Australia; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria
Rodrigo B. Mansur, Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Pawan K. Maurya, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, RS, Brazil
Roger S. McIntyre, Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; The Brain and Cognition Discovery Foundation, Toronto, ON, Canada
Elisa Mingotto, Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Como, Italy
Fabio Molina, Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
Fabiano Nery, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Anne Orgler Sordi, Center for Drug and Alcohol Research, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
Ives Cavalcante Passos, Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Department of Psychiatry, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
Luis Rodrigo Patino, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Giampaolo Perna, Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Como, Italy; Department of Psychiatry and Neuropsychology, University of Maastricht, Maastricht, The Netherlands; Department of Psychiatry and Behavioral Sciences, Leonard Miller School of Medicine, University of Miami, Miami, FL, USA
Lucas B. Rizzo, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, RS, Brazil; Department of Psychiatry, University of Tuebingen, Tuebingen, Germany
Francisco Romo-Nava, Department of Psychiatry and Mental Health, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Mexico City, DF, Mexico; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Adriane R. Rosa, Laboratory of Molecular Psychiatry, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Department of Pharmacology and Postgraduate Program in Pharmacology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
Silvia Bassani Schuch-Goi, Center for Drug and Alcohol Research, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
Luis Guilherme Streb, Hospital Nossa Senhora da Conceicao, Porto Alegre, RS, Brazil
Susannah J. Tye, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA; Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA; School of Psychology, Deakin University, Burwood, VIC, Australia; Queensland Brain Institute, The University of Queensland, St Lucia, QLD, Australia
Gustavo Vazquez, International Consortium for Bipolar and Psychotic Disorder Research, McLean Hospital, Belmont, MA, USA; Department of Neuroscience, Palermo University, Buenos Aires, Argentina; Department of Psychiatry, Queens University, Kingston, ON, Canada
Eduard Vieta, Hospital Clinic, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain
Ana S. Yamagata, Department of Psychiatry, Federal University of Rio Grande do Sul (UFRGS), Sao Paulo, RS, Brazil
